Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
16 hedge funds and large institutions have $2.01M invested in Orgenesis Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
31% more capital invested
Capital invested by funds: $1.53M → $2.01M (+$477K)
14% more funds holding
Funds holding: 14 → 16 (+2)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$261K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$244K |
| 3 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
+$224K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$86.4K |
| 5 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
+$63.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$56K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$29.6K |
| 3 |
Citigroup
New York
|
-$4.59K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
ORGS Hedge Fund Activity: Q4 2018 in Review
16 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2018, worth a combined $2.01M — up 31% from $1.53M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ORGS positions and 6 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $261K. The largest seller was Panagora Asset Management, exiting entirely with an estimated $56K sold.
- 16 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2018, up from 14 in Q3 2018.
- Funds reported $2.01M of Orgenesis Inc. Common Stock stock for Q4 2018, up 31% quarter-over-quarter.
- 8 funds opened new Orgenesis Inc. Common Stock positions in Q4 2018 and 6 closed out, a net change of +2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q4 2018 was Geode Capital Management, an estimated $261K added.
- The largest Orgenesis Inc. Common Stock seller in Q4 2018 was Panagora Asset Management, an estimated $56K sold.
Based on aggregated 13F filings for Q4 2018.